Related Experiment Video
Updated: Feb 15, 2026

Advanced Glycation End-Products Sensitize Human Sensory-Like Neuron Cells to Capsaicin-Induced Calcium Influx
Published on: May 2, 2025
A Study of Microalbuminuria (MAU) and Advanced Glycation End Products (AGEs) Levels in Diabetic and Hypertensive
S Gawandi1, S Gangawane2, A Chakrabarti2
11Radiation Medicine Centre, Bhabha Atomic Research Centre (BARC), Mumbai, India.
Abstract:
The prevalence of non-communicable diseases like diabetes mellitus (DM) and hypertension (HTN) is growing worldwide. Both lead to nephropathy if not controlled effectively. Microalbuminuria (MAU) is recognized as an early predictor for nephropathy. Additionally, the timely detection of advanced glycation end products (AGEs) is also considered to be an important prognostic factor for diabetic nephropathies. Hence, screening for the early detection of MAU and AGEs would be an useful and relatively inexpensive laboratory test for early clinical diagnosis for the incidence of nephropathy in these diseases. This study was conducted in DM, HTN and pregnancy induced hypertensive (PIH) subjects. MAU and Nε-Carboxymethyllysine (CML) levels were estimated by in-house RIA kits in the patient groups and controls, while the total AGEs level in serum was determined by ELISA. The levels of MAU, CML and AGE-BSA were observed to be significantly higher in DM, HTN and PIH subjects compared to controls (p < 0.001). Increased serum CML and AGEs levels in DM, HTN and PIH subjects indicated ongoing glycemic damage and their susceptibility to develop renal complications.
Insights
Early detection of kidney damage in diabetes mellitus (DM), hypertension (HTN), and pregnancy-induced hypertension (PIH) is crucial. Screening for microalbuminuria (MAU) and advanced glycation end products (AGEs) can help identify at-risk patients.
Area of Science:
- Nephrology
- Endocrinology
- Clinical Chemistry
Background:
- Non-communicable diseases like diabetes mellitus (DM) and hypertension (HTN) are globally prevalent and can lead to nephropathy.
- Microalbuminuria (MAU) is an early indicator of kidney damage, while advanced glycation end products (AGEs) are important prognostic factors in diabetic nephropathy.
Purpose of the Study:
- To evaluate microalbuminuria (MAU) and advanced glycation end products (AGEs) as early biomarkers for nephropathy in patients with DM, HTN, and pregnancy-induced hypertension (PIH).
Main Methods:
- Serum levels of MAU and Nε-Carboxymethyllysine (CML) were measured using in-house RIA kits.
- Total AGEs in serum were quantified using ELISA.
- Levels were compared between patient groups (DM, HTN, PIH) and healthy controls.
Main Results:
- MAU, CML, and AGE-BSA levels were significantly elevated (p < 0.001) in DM, HTN, and PIH subjects compared to controls.
- Increased serum CML and AGEs suggest ongoing glycemic damage and susceptibility to renal complications.
Conclusions:
- Elevated MAU and AGEs (including CML) serve as valuable early indicators of nephropathy risk in DM, HTN, and PIH.
- These biomarkers facilitate early clinical diagnosis and intervention to prevent renal complications.
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
05:08Plate-based Large-scale Cultivation of Caenorhabditis elegans: Sample Preparation for the Study of Metabolic Alterations in Diabetes
Published on: August 24, 2018
Related Concept Videos
Bioavailability Study Design: Healthy Subjects Versus Patients
Hypertension III: Clinical Manifestations and Diagnostic Studies
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Hypertension I: Introduction
Hypertension II: Pathophysiology